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Our aim is to study the dynamics of pupillary abnormalities in varying severity of diabetic retinopathy. 
A non-interventional case-control study with 405 eyes of 244 subjects with diabetes, and 41 eyes of 26 
subjects with no history of diabetes was done. Diabetes group was classified according to retinopathy 
severity: no retinopathy, mild non-proliferative diabetic retinopathy (NPDR), moderate NPDR, severe 
NPDR and proliferative diabetic retinopathy (PDR). After dark adaptation, pupil size and flashlight 
response were captured with an infrared camera. Baseline Pupil Diameter (BPD), Amplitude of Pupillary 
Constriction (APC), Velocity of Pupillary Constriction (VPC) and Velocity of Pupillary Dilatation (VPD). 
Compared to controls, mean BPD decreased with increasing severity of diabetic retinopathy. Mean 
APC in control group was 1.73 ± 0.37 mm and reduced in mild NPDR (1.57 ± 0.39, p = 1.000), moderate 
NPDR (1.51 ± 0.44, p = 0.152) and found to be significant reduced in severe NPDR (1.43 ± 0.48, 
p = 0.001) and PDR (1.29 ± 0.43, p = 0.008). Compared to controls, mean VPC decreased progressively 
with increasing severity of retinopathy, with a maximal difference in the PDR group. Mean VPD as 
compared to the control group was significantly reduced in the no DR (p = 0.03), mild NPDR (p = 0.038), 
moderate NPDR (p = 0.05), PDR group (p = 0.02). We found pupillary dynamics are abnormal in early 
stages of diabetic retinopathy and progress with increasing retinopathy severity.
Diabetic Autonomic Neuropathy (DAN), although not very well explored or examined, is a common complica-
tion of diabetes. It affects the cardiovascular, gastrointestinal, genitourinary, sudomotor and ocular systems, and 
leads to considerable morbidity and mortality in subjects with diabetes1. Identification of these high-risk subjects 
is therefore crucial to improve the long-term outcomes of people suffering with diabetes.
Conventional diagnostic modality for assessing DAN include a battery of tests needing sophisticated and 
specific equipment, trained technicians and are time-consuming2. Moreover, these tests require active patient 
participation and compliance which limits its use in common clinical practice.
Dynamic pupillometry is an alternative technique that is simple, non-invasive, inexpensive and fast requir-
ing minimal patient participation, and has been studied in various disease conditions affecting the Autonomic 
Nervous System (ANS), particularly diabetes3–5.
The Pupil Light Reflex (PLR) is under the direct control of the Autonomic Nervous System (ANS). The pupil’s 
size is controlled by circular (sphincter) and radial muscles of the iris. The circular muscle is innervated by the 
parasympathetic nervous system (PNS) while the radial muscle is innervated by the sympathetic nervous system 
(SNS) fibers. Thus, the PLR allows the evaluation of both the PNS and SNS dysfunctions. Dysfunction of the PNS 
causes relative mydriasis in light conditions and diminished constriction to light. Dysfunction of the SNS causes 
relative miosis of the pupil in the dark and increased re-dilatation lag.
Although, there are many studies that showed abnormal pupillary dynamics in diabetes, suggestive of 
autonomic dysfunction, its relation to the varying severity of diabetic retinopathy (DR) has not been explored 
extensively4,6–10. Clark studied ocular autonomic dysfunction in 28 diabetic subjects with proliferative diabetic 
retinopathy11. In a small cohort of 30 diabetic subjects, Datta et al. studied ocular autonomic dysfunctions in three 
broad groups of diabetic retinopathy: no retinopathy (n = 10), non-proliferative diabetic retinopathy (n = 10) and 
proliferative diabetic retinopathy (n = 10)12. In this study, we sought to examine the pupillary dynamics along 
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the entire spectrum of DR: no DR, mild NPDR, moderate NPDR, severe NPDR and PDR, and compare it age 
matched normals.
Study Population and Methodology
The Institutional Review Board of Vision Research Foundation approved this prospective study. 405 eyes of 244 
subjects with diabetes above the age of 35 years were examined in patients attending a diabetic screening camp. 
26 age-matched subjects with no history of diabetes were recruited as the control group. 41 eyes of these healthy 
subjects were analyzed.
Subjects who had an irregular and non-symmetrical pupil, iris abnormality including rubeosis iridis, optic 
nerve diseases, and on medication (local and systemic) known to affect the ANS were excluded from the study. 
We also excluded patients who had asymmetric DR grading between eyes. Systemic conditions known to affect 
the ANS like Parkinson disorder were also excluded. Informed consent was taken from all participants, and the 
tenets of the Declaration of Helsinki was followed.
After a brief initial history, preliminary ophthalmic examination on slit-lamp was done. Subjects were 
requested to sit for 15 minutes in a dark room, to allow for dark adaptation, before pupillography was carried out. 
Pupil measurements were performed with an 1/3 inch infrared camera and flash light (10 ws xenon flash lamp, 
Orion, Nidek Technologies, Italy). Pupil diameter was continuously measured with infrared light with wavelength 
ranging between 760 nm to 870 nm. Pupil size and the pupillary response to flashlight were captured and plotted 
against time.
Following parameters were measured from the graph (Fig. 1): Dark-adapted Baseline pupillary diameter 
(BPD) was measured before exposure to the flash of light (point a). The amplitude of pupillary constriction 
(APC) to the flash of the light (in mm) and the time (t1) taken was measured from the graph (between point b 
and c). The velocity of pupillary constriction (VPC) was calculated as the speed of constriction (distance divided 
by the time) in mm/sec. The amplitude of pupil re-dilatation after maximum constriction (in mm) and time (t2) 
taken (in sec.) was measured from the graph (between point c and d). Velocity of pupillary dilatation (VPD) was 
calculated as the speed of re-dilatation (distance divided by time) in mm/sec.
Diabetic retinopathy was graded clinically using Klein’s classification (Modified Early Treatment Diabetic 
Retinopathy Study ETDRS classification). Retinal photographs were obtained after pupillary dilatation (Carl Zeiss 
fundus camera; Visucamlite, Jena, Germany); all patients underwent 45°, 4-field stereoscopic digital photography 
(posterior pole, nasal, superior, and inferior). All photographs were graded by two independent observers in a 
masked fashion; the grading agreement was high (κ = 0.83). Subsequently, the eyes were classified according to 
the following grouping: 147 diabetic eyes with no DR (no-DR), 53 eyes with mild non-proliferative diabetic retin-
opathy (NPDR), 146 eyes with moderate NPDR, 33 eyes with severe NPDR and 26 eyes with PDR.
A statistical package for Social Sciences-SPSS (version 21.0) was used for statistical analysis. All the data were 
expressed as mean ± SD. The age and baseline pupillary diameter were compared between groups using One-way 
ANOVA. Comparison between control group and different stages of DR group were made using General Linear 
Model Repeated Measures analysis to overcome the influence of inter-eye dependency since both the eyes were 
used for analyses in most of the subjects. The statistical significance was assumed at p values < 0.05.
Synopsis. Dynamics of pupillary reaction in varying diabetic retinopathy severity was studied to understand 
autonomic nervous system dysfunction in diabeties. We found that alteration of pupillary dynamics even in early 
stages of diabetic retinopathy which progresses with increase in severity.
Data availability statement. The datasets generated during and/or analysed during the current study are 
available from the corresponding author on reasonable request.
Figure 1. A typical pupillary light reaction graph obtained from the infrared pupillometer.
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Results
The diabetes group constituted 105 males and 139 females, with a mean age of 44 ± 8.5 years. The non-diabetes 
group constituted 15 males and 11 females, with a mean age of 43.1 ± 5.7 years. The mean age was compared 
between groups and found to have no statistically significant difference between group (p = 0.723).
Table 1 shows the pupillary dynamics parameters expressed as mean and SD in the various groups. The mean 
BPD in the control group was 4.39 ± 0.60 mm. Compared to the control group, the mean BPD decreased with 
increasing severity of diabetic retinopathy, with a demonstrable trend towards significance (p = 0.06 in PDR 
group; Fig. 2). However, overall there was no statistically significant difference in BPD (p = 0.582).
The mean APC in the control group was 1.73 ± 0.37 mm (Fig. 3). Compared to the control group the mean 
APC decreased, however not statistically significant in no DR (1.69 ± 0.49, p = 1.000), mild NPDR (1.57 ± 0.39, 
p = 1.000) and moderate NPDR (1.51 ± 0.44, p = 1.000), and found to be statistically significant in severe 
NPDR (1.43 ± 0.48, p = 0.001) and PDR (1.29 ± 0.43 mm, p = 0.008). The mean VPC in the control group was 
2.12 ± 0.38 mm/sec (Fig. 4). The mean VPC decreased with increasing severity of diabetic retinopathy, although 
not statistically significant. The mean VPD in the control group was 0.45 ± 0.20 mm/sec (Fig. 5). Compared 
to controls, the mean VPD decreased progressively in no DR (0.40 ± 0.16 mm/sec; p = 0.035), mild NPDR 
(0.38 ± 0.18 mm/sec; p = 0.038), moderate NPDR (0.43 ± 0.22 mm/sec; p = 0.005) and PDR (0.38 ± 0.13 mm/sec; 
p = 0.02).
Discussion
This study found a smaller BPD, reduced APC, VPC and VPD in response to light in subjects with diabetes. 
Our results are in agreement with the previous studies4,6–10. More importantly, we found these abnormalities are 
present in subjects with early stages of diabetic retinopathy which increases progressively along the spectrum of 
retinopathy.
Smith and Dewhirst10, concluded that the resting pupillary diameter in the dark-adapted state is mainly under 
the SNS, and that smaller pupils in subjects with diabetes is a sign of sympathetic dysfunction. We found the 
mean BPD was smaller in patients with diabetes as compared to the non-diabetes group, although not significant 
(Fig. 2). However, it was interesting to note that in PDR group, this changes was approaching statistical signifi-
cance, with the value of p = 0.058.
Although PLR as a whole is governed both by SNS and PNS, the different phases have differential innervation 
by SNS and PNS. During the constriction phase, PNS plays a dominant role, while contribution by the SNS is 
Parameters No Diabetes
Diabetes
No DR Mild DR Moderate DR Severe DR PDR
BPD 4.39 ± 0.60 4.38 ± 0.63 4.19 ± 0.50 4.31 ± 0.62 4.29 ± 0.75 4.14 ± 0.42**
APC 1.73 ± 0.37 1.69 ± 0.49 1.57 ± 0.39 1.51 ± 0.44 1.43 ± 0.48* 1.29 ± 0.43*
VPC 2.12 ± 0.38 2.12 ± 0.57 1.98 ± 0.54 1.96 ± 0.53 1.88 ± 0.59 1.86 ± 0.66
VPD 0.45 + 0.20 0.40 ± 0.16* 0.38 ± 0.18* 0.43 ± 0.22* 0.49 ± 0.30 0.38 ± 0.13*
Table 1. Pupillary dynamic parameters in various stages of DR. APC: Amplitude of pupillary constriction; 
VCP: Velocity of pupillary constriction; VPD: Velocity of pupillary re-dilatation; **p approaching statistical 
significance; *p is statistically significant.
Figure 2. The mean baseline pupillary diameter (in mm) in various groups.
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negligible. However, at the beginning of the re-dilatation phase, both PNS and SNS innervate the pupil8. Thus, the 
parameters relating to pupillary constriction (amplitude and velocity) may be considered as a PNS-related PLR 
parameters, uncontaminated by the SNS activity. Although it been argued that these parameters depend on the 
baseline pupillary diameter (influenced by the SNS), previous research suggests that PNS dysfunction is solely 
responsible for the constriction phase5. In the first meta-analysis to evaluate the sensitivity of PLR to diagnose 
parasympathetic dysfunction, Wang et al. found APC and VPC parameters to be highly sensitive13. We found 
that both APC and VPC decrease with increasing severity of DR (Figs 3 and 4). This observation of early PNS 
dysfunction which further increases along the spectrum of DR implies early parasympathetic neuronal damage 
in patients with diabetes, even in those who do not have DR.
We found the mean VPD in the diabetic group was significantly slower than the control group (Fig. 5). 
Because of the dual innervation (both PNS and SNS) during the re-dilatation phase of PLR, our finding relating 
to this simply denotes ANS dysfunction in diabetes. Any further interpretation of this finding is difficult.
We showed evidence of early ANS dysfunction in patients with diabetes, which increases progressively with 
the severity of retinopathy. Datta et al. showed evidence of significant PNS dysfunction in subjects with diabetes 
with NPDR as compared to healthy subjects12. Clark found abnormal pupil reflexes in 88.5% of patients with 
proliferative diabetic retinopathy11.
Figure 3. The mean amplitude of pupillary constriction (in mm) in various groups.
Figure 4. The mean velocity of pupillary constriction (in mm/s) in various groups.
www.nature.com/scientificreports/
5Scientific REPORtS |  (2018) 8:5636  | DOI:10.1038/s41598-018-24015-9
Evidence of significant impairment of PLR in patients with diabetes with severe grades of retinopathy, cannot 
be attributed exclusively to retinopathy severity. Perhaps it represents a significant correlation between diabetic 
complications, retinopathy and autonomic dysfunction. Smith suggested that ocular autonomic nervous system 
dysfunction occurs before cardiovascular autonomic dysfunction14. A strong association have also been shown 
between the severity of diabetic retinopathy and cardiovascular autonomic dysfunction in patients with diabe-
tes15. Several pathways have been suggested in the pathogenesis of DAN. Hyperglycemia-induced activation of 
polyol pathway, Protein kinase C, increased oxidative stress, reduced nitric oxide production, autoimmune mech-
anisms, deficiency of neurotrophic growth factors, and formation of advanced glycosylation end products have 
been implicated16–21. These multifactorial pathways act through activation of polyADP ribosylation and depletion 
of ATP, resulting in cell necrosis and activation of genes involved in neuronal damage22.
Although ANS dysfunction is crucial for abnormal PLR, an additional contributory mechanism also results 
from structural changes of the iris in diabetes. Fujii et al. studied the ultrastructure abnormalities in iris specimen 
obtained from patients with diabetes mellitus23. They found significant structural changes in the dilator pupillae 
and constrictor pupillae muscles, their nerves endings and evidence of nerve fibers loss. In an interesting study 
done by Nitoda et al., they showed that nerve fiber alterations of the corneal sub-basal nerve plexus progress in 
parallel with DR and peripheral diabetic neuropathy using confocal microscopy24.
The major strengths of the study are substantial sample size and standard photographic diagnosis of diabetic 
retinopathy by two independent graders in a masked fashion, with high inter-grader agreement. The study was 
performed using a fundus camera with a simple in-built infra-red pupillometer. Using this simple pupillometer 
we could compute the important pupillary dynamics parameters needed to evaluate ANS dysfunction. However, 
custom-built pupillometers used in some studies allows computation of a large number of parameters and should 
be noted as one of the limitations of our study25. The other limitation of our study is, being a diabetic screening 
camp based study, an equal number of patients could not be recruited in the study groups. However we believe 
that we have sufficient numbers in each group and use of the robust General Linear Model Repeated Measures 
analysis to overcome the influence of inter-eye dependency makes our deduction reasonably valid However, it 
would be interesting to verify our results in a large population based cohort sample, specially BPD and VPC 
parameters which although showed a decreasing trend, however was not found to be statistically significant.
Our study provides novel evidence of early ANS dysfunction in the natural history of diabetes, which pro-
gresses with retinopathy severity. Dynamic pupillometry is a valuable tool for the early detection of ANS dys-
function and its utility in DAN screening, which starts even in patients with no evidence of diabetic retinopathy, 
as observed in our study. This simple and inexpensive technique can potentially improve the outcome of patients 
with DAN by detecting it at sub-clinical stages. Exploring pupillary dynamics as a screening tool for DAN in 
larger population-based studies and its co-relation with the presence or absence of cardiovascular autonomic 
neuropathy is needed.
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